|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,001.35 USD | -0.70% |
|
-0.63% | -6.82% |
| 05:13pm | Eli Lilly to invest $3 billion in China over next decade | RE |
| 04:51pm | Eli Lilly: Announces strategic partnership with Pharmaron, expected investment of $200 mln | RE |
| Capitalization | 895B 768B 694B 665B 1,214B 82,164B 1,253B 8,178B 3,275B 39,391B 3,357B 3,286B 141,039B | P/E ratio 2026 * |
29.4x | P/E ratio 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise value | 910B 782B 706B 676B 1,235B 83,596B 1,274B 8,321B 3,332B 40,078B 3,416B 3,343B 143,496B | EV / Sales 2026 * |
11.1x | EV / Sales 2027 * | 9.4x |
| Free-Float |
99.81% | Yield 2026 * |
0.66% | Yield 2027 * | 0.74% |
Last Transcript: Eli Lilly and Company
| 1 day | -0.70% | ||
| 1 week | -0.63% | ||
| Current month | -4.81% | ||
| 1 month | -2.31% | ||
| 3 months | +0.78% | ||
| 6 months | +32.70% | ||
| Current year | -6.82% |
| 1 week | 965.6 | 1,012 | |
| 1 month | 965.6 | 1,067 | |
| Current year | 965.6 | 1,133.95 | |
| 1 year | 623.78 | 1,133.95 | |
| 3 years | 317.24 | 1,133.95 | |
| 5 years | 178.58 | 1,133.95 | |
| 10 years | 64.18 | 1,133.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 58 | 01/01/2017 |
Lucas Montarce
DFI | Director of Finance/CFO | 49 | 09/09/2024 |
| Chief Tech/Sci/R&D Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 65 | 01/01/2005 |
Ralph Alvarez
BRD | Director/Board Member | 69 | 01/04/2009 |
| Director/Board Member | 54 | 12/12/2011 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.70% | -0.63% | +20.68% | +217.87% | 895B | ||
| +0.46% | -1.23% | +45.32% | +60.75% | 587B | ||
| -0.19% | -2.93% | +4.78% | +51.63% | 401B | ||
| -1.61% | -8.61% | +10.59% | +24.09% | 345B | ||
| -0.57% | -5.31% | +26.33% | +61.80% | 300B | ||
| -0.94% | -4.08% | +26.06% | +35.43% | 306B | ||
| -0.02% | -2.29% | +22.95% | +8.73% | 289B | ||
| -0.41% | -0.42% | +14.68% | +64.76% | 202B | ||
| +1.32% | +0.49% | +26.75% | +86.87% | 184B | ||
| +0.53% | +0.92% | -53.31% | -49.65% | 171B | ||
| Average | -0.23% | -1.14% | +14.48% | +56.23% | 368.14B | |
| Weighted average by Cap. | -0.34% | -1.51% | +19.56% | +84.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 82.11B 70.51B 63.74B 61.03B 111B 7,542B 115B 751B 301B 3,616B 308B 302B 12,946B | 94.81B 81.41B 73.59B 70.46B 129B 8,708B 133B 867B 347B 4,175B 356B 348B 14,947B |
| Net income | 30.39B 26.1B 23.59B 22.59B 41.25B 2,791B 42.55B 278B 111B 1,338B 114B 112B 4,792B | 36.2B 31.09B 28.1B 26.9B 49.14B 3,325B 50.69B 331B 133B 1,594B 136B 133B 5,708B |
| Net Debt | 15.59B 13.39B 12.1B 11.59B 21.16B 1,432B 21.83B 143B 57.06B 686B 58.5B 57.26B 2,458B | -3.14B -2.7B -2.44B -2.33B -4.26B -288B -4.4B -28.7B -11.49B -138B -11.78B -11.53B -495B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/03/26 | 1,001.35 $ | -0.70% | 1,663,668 |
| 09/03/26 | 1,008.39 $ | +1.82% | 2,802,169 |
| 06/03/26 | 990.33 $ | +0.72% | 2,627,805 |
| 05/03/26 | 983.26 $ | -2.02% | 3,774,397 |
| 04/03/26 | 1,003.57 $ | -0.41% | 1,965,539 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LLY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















